je.st
news
TransCelerate selects Cognizant to develop first-of-its-kind, subscription-based platform
2014-07-25 09:03:06| IT Services - Topix.net
Cognizant today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials.
Tags: develop
platform
selects
cognizant
Category:Information Technology
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||